Responsive nanoparticles deliver ARV-771 to tumor cells
A proof-of-concept nanoparticle system used hyaluronic acid for CD44-mediated tumor-cell targeting and glutathione-triggered disassembly to release ARV-771 and enable BRD4 ...
A proof-of-concept nanoparticle system used hyaluronic acid for CD44-mediated tumor-cell targeting and glutathione-triggered disassembly to release ARV-771 and enable BRD4 ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine